Analysts: Pacira Pharmaceuticals Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
33.73USD
10:48am EDT
33.73USD
10:48am EDT
Price Change (% chg)
$-0.38 (-1.11%)
$-0.38 (-1.11%)
Prev Close
$34.11
$34.11
Open
$31.00
$31.00
Day's High
$34.92
$34.92
Day's Low
$30.75
$30.75
Volume
126,571
126,571
Avg. Vol
116,882
116,882
52-wk High
$35.86
$35.86
52-wk Low
$14.46
$14.46
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Buy | -0.35 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 3 | 3 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.40 | 1.40 | 1.40 | 1.40 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 4 | 20.31 | 21.50 | 17.53 | -- |
| Quarter Ending Dec-13 | 4 | 24.72 | 26.90 | 21.47 | -- |
| Year Ending Dec-13 | 5 | 74.39 | 78.00 | 65.64 | 92.30 |
| Year Ending Dec-14 | 5 | 138.12 | 157.40 | 80.00 | 190.94 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 5 | -0.35 | -0.29 | -0.44 | -- |
| Quarter Ending Dec-13 | 5 | -0.23 | -0.17 | -0.36 | -- |
| Year Ending Dec-13 | 5 | -1.70 | -1.55 | -2.00 | -0.29 |
| Year Ending Dec-14 | 5 | 0.40 | 0.63 | 0.21 | 1.66 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 13.22 | 11.59 | 1.64 | 12.38 |
| Quarter Ending Dec-12 | 9.83 | 10.45 | 0.62 | 6.29 |
| Quarter Ending Sep-12 | 7.85 | 8.49 | 0.64 | 8.10 |
| Quarter Ending Jun-12 | 8.77 | 12.34 | 3.57 | 40.77 |
| Quarter Ending Mar-12 | 7.59 | 7.80 | 0.21 | 2.77 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 20.31 | 20.31 | 19.81 | 19.81 | -- |
| Quarter Ending Dec-13 | 24.72 | 24.72 | 24.72 | 24.72 | -- |
| Year Ending Dec-13 | 74.39 | 74.39 | 74.39 | 74.39 | 92.30 |
| Year Ending Dec-14 | 138.12 | 138.12 | 138.12 | 138.12 | 190.94 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: New Constructs, LLC
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates